Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

Biotech startup Enveda has raised a $130 million Series C, the Colorado company said Thursday morning.

Founded and led by early …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Sanofi ends deal for a rare disease drug after FTC voices monopoly concerns

In its latest bid to police the pharmaceutical industry, the U.S. Federal Trade Commission sought to block Sanofi from licensing a Pompe disease treatment made

December 11, 2023

Consolidated interim results as per June 30th,2023 – Biotech Investments

EQS-News: Vitruvia Medical AG / Key word(s): Half Year Results/Half Year Report Vitruvia Medical AG: Consolidated interim results as per June 30th,2023 29.09.2023 / 13:15

September 30, 2023

The potential of AI in pharma R&D – Pharmaceutical Technology

Developing a new drug is a monumental achievement — the reward of years of research and innovation. Successful innovation requires enormous effort from countless project

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.